Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amedisys Inc - Common Stock (NQ:AMED)

92.98 +0.14 (+0.15%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Amedisys Inc - Common Stock

< Previous 1 2 3 4 5 Next >
Why UnitedHealth Stock Is Down Today
Via The Motley Fool
3 Stocks to Gain From Trump’s Family Caregiver Tax Credits
President Trump has spoken about implementing a family caregiver tax credit during his presidential campaign to ease the burden on caregivers, here's who gains. 
Via MarketBeat
Topics Government
Exposures Political
UnitedHealth Group Q4 Earnings Preview: First Report Since Insurance CEO's Murder Comes With Questions On Company's Future
UnitedHealth shares a quarterly report for the first time since the death of insurance unit leader Brian Thompson. A look at the estimates and key items to watch. 
Via Benzinga
UnitedHealth Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Via Benzinga
Amedisys and UnitedHealth Extend Merger Deadline - What's Going On?
Amedisys and UnitedHealth extend their $3.3B merger deadline to 2025, amid DOJ scrutiny over competition concerns in the home health market. 
Via Benzinga
Is NASDAQ:AMED suited for quality investing?
AMEDISYS INC (NASDAQ:AMED) may be suited for quality investing, we'll explore why in this article. 
Via Chartmill
What 11 Analyst Ratings Have To Say About Amedisys
Via Benzinga
Analyst Ratings for Amedisys
Via Benzinga
Amedisys, Rigetti Computing And Other Big Stocks Moving Higher On Friday
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
What's Going On With UnitedHealth Stock?
UnitedHealth shares have declined 5.3% over the past week. The company faces a significant legal challenge to its $3.3 billion acquisition of Amedisys. 
Via Benzinga
UnitedHealth's Optum Defends Multi-Billion Dollar Amedisys Deal, Ensures Competitive Landscape
An aging U.S. population is increasing demand for home health care. The Optum-Amedisys merger, with divestitures to VitalCaring, aims to balance growth and competition. 
Via Benzinga
Justice Department Moves To Block UnitedHealth's Amedisys Takeover: What's Going On?
UnitedHealth Group Inc (NYSE:UNH) shares are trading lower Tuesday. The U.S. Justice Department is moving to block the company's multi-billion acquisition of Amedisys Inc (NASDAQ:AMED). 
Via Benzinga
Contessa Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model
Guiding an Improved Dementia Experience (GUIDE) Model Aims to Increase Care Coordination, Support for Caregivers 
From Amedisys, Inc.
Via GlobeNewswire
AMED Stock Earnings: Amedisys Beats EPS, Beats Revenue for Q2 2024
AMED stock results show that Amedisys beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
AMED Stock Earnings: Amedisys Beats EPS, Beats Revenue for Q1 2024
AMED stock results show that Amedisys beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes
It's not just enough for a company to pay a dividend, investors should look for dividend growth stocks that can continue to pay. 
Via InvestorPlace
3 Stocks To Turn $1,000 Into $10,000 in 10 Years
There are a few simple rules for investing for 10x returns but they are among the most difficult to follow. 
Via InvestorPlace
3 Stocks Profiting from America’s Long-Term Care Crisis
These long-term care stocks provide older Americans with the care they need and the income to pay for it well into retirement. 
Via InvestorPlace
Cantor Fitzgerald Maintains Neutral Rating for Amedisys: Here's What You Need To Know
Via Benzinga
The 3 Best Stock Picks for This Week
The best stock picks for this week have long-term aims such as high earnings and growth for your portfolio. 
Via InvestorPlace
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: EchoStar Corporation (Nasdaq - SATS), Sovos Brands, Inc. (Nasdaq - SOVO), Reata Pharmaceuticals, Inc. (Nasdaq - RETA), Amedisys, Inc. (Nasdaq – AMED)
From Brodsky & Smith LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Reata Pharmaceuticals, Inc. (Nasdaq – RETA), Talaris Therapeutics, Inc. (Nasdaq – TALS), Inpixon® (Nasdaq – INPX), Amedisys, Inc. (Nasdaq – AMED)
From Brodsky & Smith LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE – AEL), Amedisys, Inc. (Nasdaq – AMED), Sigilon Therapeutics, Inc (Nasdaq – SGTX)
From Brodsky & Smith LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: American Equity Investment Life Holding Company (NYSE – AEL), Amedisys, Inc. (Nasdaq – AMED), Sigilon Therapeutics, Inc (Nasdaq – SGTX)
From Brodsky & Smith LLC
Via GlobeNewswire
Is UnitedHealth Group Stock a Buy Now?
The nation's largest health insurer has seen its shares fall despite a strong start to the year. 
Via The Motley Fool
SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Amedisys, Inc. (Nasdaq – AMED)
From Brodsky & Smith LLC
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For July 6, 2023
Via Benzinga
Meta Platforms To Rally Around 14%? Here Are 10 Other Analyst Forecasts For Thursday
Morgan Stanley cut the price target for ArcBest Corporation (NASDAQ: ARCB) from $136 to $125. Morgan Stanley analyst Ravi Shanker maintained an Overweight rating. ArcBest shares fell 3.3% to close at... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2023
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.